June 26th, 2019
•A method for establishing afatinib-resistance cell lines from lung adenocarcinoma PC-9 cells was developed, and resistant cells were characterized. The resistant cells can be used to investigate epidermal growth factor receptor tyrosine kinase inhibitor-resistance mechanisms, applicable for patients with non-small cell lung cancer.
Related Videos
Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure (Video) | JoVE
Development of a Human Preclinical Model of Osteoclastogenesis from Peripheral Blood Monocytes Co-cultured with Breast Cancer Cell Lines (Video) | JoVE
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues (Video) | JoVE
Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression (Video) | JoVE
Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions (Video) | JoVE
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines (Video) | JoVE
Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines (Video) | JoVE
Establishment and Characterization of Small Bowel Neuroendocrine Tumor Spheroids (Video) | JoVE
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models (Video) | JoVE
Analysis of Side Population in Solid Tumor Cell Lines (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved